Sox6 inhibits the growth of human colorectal cancer and hepatocellular carcinoma, and decreased expression of SOX6 is associated with a poor prognosis in patients with hepatocellular carcinoma 16, 17. This evidence concerns the gene SOX6 and hepatocellular carcinoma.